Home / Indicator library / Biotechnology and Medical Care / PG (6550) overview
PG (6550) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for PG, on one pagePG (6550) snapshot, key figures
Price / earnings
—
Price / book
—
Dividend yield
—
Revenue YoY (2026-08)
202.6%
Monthly revenue (2026-08)
TWD 0.00bn
Sector
Biotechnology and Medical Care
Values above are the official-source snapshot for PG (6550). We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.
Seven-dimension checkup for this ticker →
Valuation river
→Loading…
Financial quality
→F-score quality checks passed: 2 of 6 checks that could be computed
Revenue growth
→Monthly revenue, 2026-08: +202.6% year on year
Ownership structure
→Large holders at 72.97%, -0.26 points week on week · insider pledge 0.0% as of 2026-08-31
Events, last 90 days
→Loading…
Yield river
→Loading…
Valuation models
→Loading…
Adjusted-price candles
→Loading…
6550: common questions
How fast is 6550's revenue growing?
6550 reported 202.6% year-on-year monthly revenue growth for 2026-08, from the official monthly revenue filing.
Other Biotechnology and Medical Care tickers
159 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.
Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.